Human LMP2 (HLA-A*02:01) Protein, His-Avi Tag yeasen
$319.00
In stock
SKU
93023ES25
Product Description
The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
Specifications
| Synonyms | MHC; RMF; LMP2; LMP-2; Macropain chain 7; Proteasome chain 7; PSMB9 Uniprot No. A0A140T913(HLA-A*02:01)&P61769(B2M)&CLGGLLTMV] |
| Source | Recombinant Human LMP2 (HLA-A*02:01) Protein is expressed from Expi293 with His tag and Avi tag at the C-terminal. It contains Gly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M) and CLGGLLTMV peptide |
| Source | The protein has a predicted MW of 50.3 kDa. Due to glycosylation, the protein migrates to 52-56 kDa based on Tris-Bis PAGE result. |
| Purity | > 95% as determined by SDS-PAGE and HPLC. |
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| Endotoxin | <1 EU per 1μg of the protein by the LAL method. |
| Reconstitution | Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water. |
Storage
The product should be stored at -25~-15℃ for 1 year from date of receipt. 2-7 days, 2 ~8 °C under sterile conditions after reconstitution. 3 months, -25~-15℃ under sterile conditions after reconstitution. Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Notes
1. Please operate with lab coats and disposable gloves for your safety. 2.This product is for research use only.
Reviews
Write Your Own Review
Related Products
Check items to add to the cart or
